Article
FOXM1 functions collaboratively with PLAU to promote gastric cancer progression
13 Dec 2019
Abstract excerpt
Background: Gastric cancer (GC) is one of the main mortality cause worldwide. Previously, we found Forkhead box protein (FOXM1) or Urokinase-type plasminogen activator (PLAU) are independent prognostic markers of GC. This study aims to explore the combining prognostic efficacy and the potential insights underlying additive effect of FOXM1 to PLAU in GC progression through in-silico analyses. Method: The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
